Connect with us

Hi, what are you looking for?

press release

Skanska builds outpatient cancer center in Livingston, New – Press Release

STOCKHOLM, September 30, 2022 /PRNewswire/ — Skanska has signed a contract with RWJBarnabas Health to build an outpatient cancer center Livingston, New Jersey, UNITED STATES OF AMERICA. The contract is worth it $58 millionaround 570 million SEKwhich will be included in US orders for the third quarter of 2022.

The five-story building on the Cooperman Barnabas Medical Center campus, with a gross floor area of ​​13,000 square meters, is designed to support the care and well-being of patients. The new facility will enable outpatient cancer treatments, including four new linear accelerators and a high-dose MRI unit. A parking garage is also being built.

start of building Sep 2022and completion is scheduled for July 2025.

For more information please contact:

Mia WaltonVice President Communications, Skanska United States of America Building, Tel. +1 (240) 672 17 89
Jakob BirkelandHead of Media Relations and Public Relations, Skanska AB, Tel: +46 (0)10 449 19 57
Direct line for media, Tel. +46 (0)10 448 88 99

This and previous versions can also be found at www.skanska.com.

This information was provided to you by Cision http://news.cision.com

https://news.cision.com/skanska/r/skanska-builds-ambulatory-care-cancer-center-in-livingston–new-jersey–usa–for-usd-58m–about-sec- ,c3639349

The following files are available for download:

Show original content:https://www.prnewswire.com/news-releases/skanska-builds-ambulatory-care-cancer-center-in-livingston-new-jersey-usa-for-usd-58m-about-sec-570m-301637528. html

SOURCE Skanska

Source Story here

You May Also Like

Business

State would join dozens of others in enacting legislation based on federal government’s landmark whistleblower statute, the False Claims Act

press release

With a deep understanding of the latest tech, Erbo helps businesses flourish in a digital world.

press release

#Automotive #Carbon #Canister #Market #Projected #Hit #USD New York, US, Oct. 24, 2022 (GLOBE NEWSWIRE) —  According to a comprehensive research report by Market...

press release

Barrington Research Analyst James C.Goss reiterated an Outperform rating on shares of IMAX Corp IMAX with a Price target of $20. As theaters...